Sunday, February 7, 2016

The Amended Patent Examination Guidelines Will Come into Force in April

In response to the Supreme Court decision on last November, JPO have been preparing the amendment of patent examination guidelines to allow patent term extension (PTE) for a drug patent when the drugs is granted marketing authorization (MA) for different dosage and administration even if the drug has the same ingredients. The draft of amendment was approved by the government committee on February 4th, and it will come into force in April after the process of public comment. The amended guidelines will be applied to the examinations which are conducted after the enforcement date. 

No comments:

Post a Comment